RT Journal Article
T1 Cost-effectiveness of a primary care-based exercise intervention in perimenopausal women. The FLAMENCO Project.
A1 Špacírová, Zuzana
A1 Epstein, David
A1 García-Mochón, Leticia
A1 Aparicio, Virginia A
A1 Borges-Cosic, Milkana
A1 López Del Amo, M Puerto
A1 Martín-Martín, José J
K1 Análisis de coste-utilidad
K1 Años de vida ajustados por calidad
K1 Cost-benefit analysis
K1 Ejercicio
K1 Exercise
K1 Menopause
K1 Menopausia
K1 Mujeres
K1 Quality-adjusted life years
K1 Women
AB Adequate physical activity levels and a healthy lifestyle may prevent all kinds of non-communicable diseases, promote well-being and reduce health-care costs among perimenopausal women. This study assessed an exercise programme for perimenopausal women. A total of 150 women (aged 45-64 years) not engaged in regular physical activity were randomly assigned to either a 16 week exercise intervention or to the control group. The study was conducted from the perspective of the National Health System. Health outcomes were quality-adjusted life years (QALYs), measured by the EuroQol-5D-5L questionnaire. The total direct costs of the programme were the costs of visits to primary care, specialty care, emergency, medicines, instructor cost and infrastructure cost. The results were expressed as the incremental cost-effectiveness ratio. Sensitivity analysis was undertaken to test the robustness of the analysis. Mean QALYs over 16 weeks were.228 in the control group and.230 in the intervention group (mean difference: .002; 95% confidence interval [95%CI]: -0.005 to 0.009). Improvements from baseline were greater in the intervention group in all dimensions of the EuroQol-5D-5L but not statistically significant. The total costs at the end of the intervention were 160.38 € in the control group and 167.80 € in the intervention group (mean difference: 7.42 €; 95%CI: -47 to 62). The exercise programme had an incremental cost-effectiveness ratio of 4,686 €/QALY. The programme could be considered cost-effective, although the overall difference in health benefits and costs was very modest. Longer term follow-up is needed.
YR 2018
FD 2018-10-16
LK http://hdl.handle.net/10668/13108
UL http://hdl.handle.net/10668/13108
LA en
DS RISalud
RD Apr 11, 2025